12 articles found
An economic analysis finds Mindfulness-Oriented Recovery Enhancement saves $12 for every dollar spent on opioid misuse — more than $324,000 per patient over a lifetime.
New research demonstrates that VR-based cue exposure therapy can effectively reduce cravings in people with substance use disorders, offering a scalable digital health intervention.
Psychiatric Urgent Care of Huntsville opens as North Alabama's first same-day mental health facility, offering immediate access to psychiatric care and telemedicine services statewide
SAMHSA's updated guidance states that medication-only models for opioid use disorder are inadequate, reigniting tensions between comprehensive care ideals and the practical realities of treatment access.
The largest federally recognized tribe opens a 100-bed residential facility in Tahlequah, Oklahoma, integrating stickball, traditional gardening, and cultural practices into addiction recovery.
The POINTS Act would create a $50 million annual federal grant program for problem gambling treatment—the first dedicated funding stream as legal sports betting expands to 38 states.
Wake Forest research reveals e-cigarette taxes reduced vaping among heterosexual teens by 3-4 percentage points, yet had no effect on LGBQ youth who use nicotine to cope with bullying and emotional distress.
New ASAM Criteria volume establishes dedicated clinical standards for youth SUD treatment, emphasizing brain development, family engagement, and integrated mental health care
Advocates press Congress to expand Veterans Treatment Courts and restore VA benefits access for incarcerated veterans struggling with service-connected mental health and substance use disorders
Second round of 'transformative grants' prioritizes youth treatment expansion, school prevention programs, and mobile crisis response as state officials emphasize building complete care continuum
American Society of Addiction Medicine releases first comprehensive update to youth substance use disorder treatment standards in over a decade, addressing telehealth, trauma-informed care, and medication access.
University of Arizona trial finds 73% of participants responded to multiple psilocybin sessions, with 40% achieving remission from obsessive-compulsive disorder symptoms lasting six months.